ofloxacin has been researched along with cefotaxime in 87 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (8.05) | 18.7374 |
1990's | 29 (33.33) | 18.2507 |
2000's | 38 (43.68) | 29.6817 |
2010's | 12 (13.79) | 24.3611 |
2020's | 1 (1.15) | 2.80 |
Authors | Studies |
---|---|
Apiwattanakul, N; Endou, H; Jariyawat, S; Kanai, Y; Sekine, T; Sophasan, S; Takeda, M | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Aghatabay, NM; Dülger, B; Haciu, D; Karabiyik, T; Neshat, A; Somer, M | 1 |
Aghatabay, NM; Dulger, B; Gucin, F; Senel, M; Somer, M | 1 |
Caniça, M; Ferreira, E; Leitão, J; Manageiro, V; Mendonça, N | 1 |
Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
Aghatabay, NM; Cevik, H; Dulger, B; Mahmiani, Y | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L | 1 |
Cattoir, V; Nordmann, P; Poirel, L | 1 |
Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Aghatabay, NM; Baş, A; Dülger, B; Gücin, F; Kircali, A; Sen, G; Yazicioğlu, MB | 1 |
Girlich, D; Nordmann, P; Poirel, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Benfodda, Z; Bénimèlis, D; Boibessot, T; Dunyach-Rémy, C; Lavigne, JP; Lebeau, A; Meffre, P; Szurmant, H; Zschiedrich, CP | 1 |
Kumamoto, Y | 1 |
Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
Becker, EW; Berg, PA; Kulessa, W | 1 |
Bhutta, ZA; Farooqui, BJ; Naqvi, SH | 1 |
Maiche, AG; Teerenhovi, L | 1 |
Beaucaire, G; Beuscart, C; Caillaux, M; Chidiac, C; Karp, P; Leroy, O | 1 |
Aydin, M; Dervişoğlu, AA; Unal, S | 1 |
Boussougant, Y; Carbon, C; Farinotti, R; Weber, P | 1 |
Gentry, LO; Khoshdel, A; Price, M; Rodriguez-Gomez, G; Zeluff, BJ | 1 |
Chin, NX; Figueredo, VM; Neu, HC; Novelli, A | 1 |
Arakawa, M; Muramatsu, Y; Ozaki, K; Satou, T; Takano, M; Tasaki, K; Wada, K | 1 |
Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
Eriksson, S; Granström, L | 1 |
Declercq, J; Fabry, G; Lammens, J; Stuyck, J; Verbist, L; Verhaegen, J | 1 |
Leshem, Y; Raz, R; Rottensterich, E; Tabenkin, H | 1 |
Bakst, CM; Loughlin, KA; Rybak, MJ | 1 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Marshall, SA; Murray, PR; Washington, JA | 1 |
Jantos, C; Schiefer, HG; Schmidts, HL; Vieler, E; Weidner, W | 1 |
Kahn, JB; Madsen, PO; Malek, GH | 1 |
Bux, D; Hasan, M; Rathore, MH | 1 |
Aleksandrova, AE; Vinogradova, TI | 1 |
Mann, RD; Pearce, GL; Wilton, LV | 1 |
de Górgolas, M; Fernández Guerrero, ML; Fernández Roblas, R; Torres Perea, R; Verdejo Morcillo, C | 1 |
Arroyo, V; Bañares, R; Castells, L; Clemente, G; Follo, A; Forné, M; Guarner, C; Jimenez De Anta, MT; Llovet, JM; Marco, F; Navasa, M; Planas, R; Rimola, A; Rodés, J; Vargas, V | 1 |
Forrest, A; Hyatt, J; Nix, DE; Schentag, JJ; Strenkoski-Nix, LC; Thomas, J; Wilton, JH | 1 |
George, J; Morrissey, I | 1 |
Bertram, P; Schumpelick, V; Töns, C; Winkeltau, GJ | 1 |
Grimm, H; Jones, RN; Marshall, SA | 1 |
Breithaupt, A; Breithaupt, H; Gehrke, R; Kraemer, HJ | 1 |
Blahová, J; Králiková, K; Krcméry, V; Torsová, V | 1 |
Peters, G; Schumacher-Perdreau, F | 1 |
Cao, XT; Kneen, R; Nguyen, TA; Parry, CM; Truong, DL; White, NJ | 1 |
Shah, PM | 1 |
Azimi, PH; Brenner, RA; Clark, P; Clemens, J; Gill, V; Lin, FY; Philips, JB; Pratt, E; Regan, J; Rhoads, GG; Troendle, J; Weisman, LE | 1 |
Baril, L; Bricaire, F; Cracco, C; Delafosse, C; Derenne, JP; Lefort, Y; Morelot, C; Similowski, T | 1 |
Guttigoli, A; Zaman, MM | 1 |
Barry, AL; Brown, SD; Fuchs, PC | 1 |
Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
Boriszova, D; Glatz, K; Rozgonyi, F; Szabó, D; Szabó, G | 1 |
Brezis, M; Leibovici, L; Paul, M; Soares-Weiser, K | 1 |
Karasawa, T; Kuriyama, T; Nakagawa, K; Nakamura, S; Yamamoto, E | 1 |
Abbas, KA; Hazir, T; Khan, MA; Qazi, SA | 1 |
Díaz de Tuesta Chow-Quan, AM; Dimas Nuñez, JF; Geijo Martínez, MP; Gómez Criado, C; Herranz, CR; Saiz García, F | 1 |
Chiang, SR; Chuang, YC; Ko, WC; Lee, HC; Tang, HJ; Wang, YY | 1 |
Acosta, F; Cottagnoud, M; Cottagnoud, P; Entenza, J; Flatz, L; Kühn, F | 1 |
Alfandari, S; d'Escrivan, T; Guery, B; Roussel-Delvallez, M | 1 |
Chen, ZM; Hua, CZ; Li, JP; Shang, SQ; Sun, XF; Yu, XL | 1 |
Aslan, SL; Buyraç, Z; Colakoğlu, O; Sözmen, B; Taşkiran, B; Unsal, B | 1 |
Di Bonaventura, G; Picciani, C; Piccolomini, R; Spedicato, I | 1 |
Torres, A | 1 |
Bédos, JP; Caulin, E; Leroy, O; Saux, P | 1 |
Berlutti, F; Scazzocchio, F; Selan, L; Tarantino, U; Thaller, MC | 1 |
Caniça, M; Dias, R; Louro, D | 1 |
Benca, J; Kalavsky, E; Kiwou, M; Kovac, M; Liskova, A; Ondrusova, A; Rudinsky, B | 1 |
Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
Audhya, A; Jain, S; Nagpure, PS | 1 |
Béraud, G; Iba Ba, J; Legout, L; Mouton, Y; Senneville, E; Yazdanpanah, Y | 1 |
Cerf-Payrastre, I; Kemiche, F; Ottaviani, S; Pertuiset, E; Thibault, M | 1 |
Arija, V; Bejarano-Romero, F; Cliville-Guasch, X; de Diego, C; Gomez-Bertomeu, F; Ochoa-Gondar, O; Raga-Luria, X; Salsench, E; Vila-Corcoles, A | 1 |
Alişkan, H; Güçlü, M; Husamettin, E; Serin, E; Yakar, T | 1 |
Monescillo Francia, A | 1 |
Aguilar, L; Fenoll, A; Gimenez, MJ; Granizo, JJ; Mendez, C; Robledo, O; Vicioso, MD | 1 |
Cheong, HJ; Choi, WS; Jo, YM; Kim, HS; Kim, JY; Kim, MJ; Kim, WJ; Park, DW; Sohn, JW; Song, JY; Youn, YK | 1 |
Kim, JS; Kim, NY; Lee, KJ; Park, JS; Yun, HK | 1 |
Mohan, P; Venkataraman, J | 1 |
Akhova, AV; Nesterova, LY; Shumkov, MS; Tkachenko, AG | 1 |
Asghar, MJ; Aslam, B; Nisar, MA; Rasool, MH; Saqalein, M; Shafiq, HB; Siddique, AB; Zahoor, MA | 1 |
Debata, NK; Gaur, M; Jena, J; Sahoo, RK; Subudhi, E | 1 |
Abdelwahab, SI; Dafalla, OME; Homeida, HE; Taha, MME | 1 |
Ali, I; Aljuwayid, AM; Dilshad Alam, S; Jain, AK; Raja, R; Sillanpää, M; Yusuf, K | 1 |
3 review(s) available for ofloxacin and cefotaxime
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Oral treatment of gonorrhea and chlamydia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Chlamydia Infections; Ciprofloxacin; Doxycycline; Female; Gonorrhea; Guidelines as Topic; Humans; Male; Ofloxacin; Randomized Controlled Trials as Topic | 1994 |
Evidence based case report. Antibiotic treatment for spontaneous bacterial peritonitis.
Topics: Acute Disease; Anti-Bacterial Agents; Cefotaxime; Evidence-Based Medicine; Female; Gram-Negative Bacterial Infections; Humans; Middle Aged; Ofloxacin; Peritonitis; Randomized Controlled Trials as Topic | 2002 |
13 trial(s) available for ofloxacin and cefotaxime
Article | Year |
---|---|
Single-dose treatment of female acute uncomplicated cystitis.
Topics: Acute Disease; Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Clinical Protocols; Colony Count, Microbial; Cystitis; Fluoroquinolones; Ofloxacin; Quinolones; Recurrence; Treatment Outcome; Urine | 1992 |
Empiric treatment of serious infections in patients with cancer: randomised comparison of two combinations.
Topics: Administration, Oral; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Neoplasms; Neutropenia; Ofloxacin; Tobramycin | 1991 |
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections.
Topics: Adult; Aged; Amikacin; Bacterial Infections; Cefotaxime; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Male; Middle Aged; Ofloxacin; Piperacillin; Prospective Studies | 1991 |
Serum bactericidal activity against Enterobacteriaceae producing broad-spectrum beta-lactamases in volunteers administered ofloxacin and cefotaxime, alone or combined.
Topics: beta-Lactamases; Cefotaxime; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Escherichia coli; Humans; Klebsiella pneumoniae; Male; Ofloxacin; Random Allocation; Serratia marcescens | 1989 |
A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
Topics: Administration, Oral; Adult; Bacteria; Cefotaxime; Female; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Placebos; Prospective Studies; Randomized Controlled Trials as Topic; Single-Blind Method; Skin Diseases, Infectious; Wound Healing | 1989 |
Randomized controlled trial of appendicectomy versus antibiotic therapy for acute appendicitis.
Topics: Acute Disease; Adolescent; Adult; Aged; Appendicitis; Cefotaxime; Female; Humans; Male; Middle Aged; Ofloxacin; Pain Measurement; Pilot Projects; Prospective Studies; Tinidazole; Treatment Outcome | 1995 |
Double-blind study comparing 3-day regimens of cefixime and ofloxacin in treatment of uncomplicated urinary tract infections in women.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Cefixime; Cefotaxime; Double-Blind Method; Female; Humans; Middle Aged; Ofloxacin; Urinary Tract Infections | 1994 |
Single dose UTI prophylaxis in transurethral surgery. Oral ofloxacin vs parenteral cefotaxime.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Urethra; Urinary Tract Infections | 1995 |
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Female; Humans; Injections, Intravenous; Male; Middle Aged; Ofloxacin; Peritonitis | 1996 |
Pharmacodynamic modeling of the in vivo interaction between cefotaxime and ofloxacin by using serum ultrafiltrate inhibitory titers.
Topics: Adult; Anti-Infective Agents; Area Under Curve; Cefotaxime; Cephalosporins; Cross-Over Studies; Drug Combinations; Drug Interactions; Female; Hemofiltration; Humans; Male; Microbial Sensitivity Tests; Models, Biological; Ofloxacin | 1997 |
A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.
Topics: Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Male; Ofloxacin; Typhoid Fever | 1999 |
[Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalization].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Clavulanic Acid; Community-Acquired Infections; Drug Therapy, Combination; Female; Hospitalization; Humans; Levofloxacin; Male; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2002 |
Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefotaxime; Chi-Square Distribution; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Intensive Care Units; Levofloxacin; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Prospective Studies; Treatment Outcome | 2005 |
71 other study(ies) available for ofloxacin and cefotaxime
Article | Year |
---|---|
The interaction and transport of beta-lactam antibiotics with the cloned rat renal organic anion transporter 1.
Topics: Animals; Anion Transport Proteins; Anti-Bacterial Agents; Biological Transport; Carrier Proteins; Cell Survival; Cephaloridine; Cephalosporins; In Vitro Techniques; Kidney; Kinetics; Oocytes; p-Aminohippuric Acid; Penicillin G; Rats; Recombinant Proteins; Xenopus laevis | 1999 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand.
Topics: Anti-Bacterial Agents; Antifungal Agents; Cadmium; Chelating Agents; Disk Diffusion Antimicrobial Tests; Ferrous Compounds; Ligands; Magnetic Resonance Spectroscopy; Metals, Heavy; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Organomercury Compounds; Organometallic Compounds; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Structure-Activity Relationship; Zinc | 2007 |
Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex.
Topics: Anti-Infective Agents; Bacteria; Disk Diffusion Antimicrobial Tests; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Organometallic Compounds; Palladium; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman; Yeasts | 2007 |
Spread of extended-spectrum beta-lactamase CTX-M-producing escherichia coli clinical isolates in community and nosocomial environments in Portugal.
Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Microbial Sensitivity Tests; Middle Aged; Portugal | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds.
Topics: Anti-Infective Agents; Aza Compounds; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Ligands; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis; Spectrum Analysis, Raman | 2009 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Apoptosis; Bacteria; Cattle; Cell Line, Tumor; DNA; Humans; Macrocyclic Compounds; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Structure; Spectroscopy, Fourier Transform Infrared; Spectrum Analysis, Raman; Yeasts | 2009 |
First isolation of the blaOXA-23 carbapenemase gene from an environmental Acinetobacter baumannii isolate.
Topics: Acinetobacter baumannii; beta-Lactamases; DNA, Bacterial; Escherichia coli; France; Genes, Bacterial; Water Microbiology | 2010 |
The Rational Design, Synthesis, and Antimicrobial Properties of Thiophene Derivatives That Inhibit Bacterial Histidine Kinases.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Design; Enzyme Inhibitors; Histidine Kinase; Humans; Microbial Sensitivity Tests; Models, Molecular; Signal Transduction; Thiophenes | 2016 |
[A clinical study on postantibiotic effect (PAE) and its application to chemotherapy for complicated cystitis with an automatic simulator of urinary drug concentration].
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Automation; Cefixime; Cefotaxime; Cystitis; Enterobacter cloacae; Humans; Models, Biological; Ofloxacin; Staphylococcus epidermidis; Urinary Bladder | 1992 |
[Recurrent agranulocytosis after taking calcium dobesilate].
Topics: Agranulocytosis; Calcium Dobesilate; Cefotaxime; Drug Hypersensitivity; Female; Humans; Lymphocyte Activation; Middle Aged; Ofloxacin; Pyoderma; Recurrence | 1992 |
Therapy of multidrug resistant typhoid in 58 children.
Topics: Adolescent; Ampicillin Resistance; Aztreonam; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Microbial; Humans; Infant; Infant, Newborn; Ofloxacin; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
[An epidemiologic study of the antibiotic susceptibility of bacteria isolated from patients with urinary tract infections].
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Prevalence; Turkey; Urinary Tract Infections | 1989 |
In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
Topics: Anti-Bacterial Agents; Cefotaxime; Chemical Phenomena; Chemistry; Ciprofloxacin; Culture Media; Drug Resistance, Microbial; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Hydrogen-Ion Concentration; Imipenem; Magnesium; Ofloxacin; Oxazines; Pseudomonas; Quinolines; Quinolones; Thienamycins | 1988 |
[An infection route of meningococcal meningitis and eradication of carriers].
Topics: Carrier State; Cefixime; Cefotaxime; Female; Humans; Meningitis, Meningococcal; Middle Aged; Ofloxacin | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Salmonella typhi osteomyelitis.
Topics: Adult; Cefotaxime; Forearm; Humans; Male; Ofloxacin; Osteomyelitis; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever; Wrist | 1994 |
In-vitro comparison of DU-6859a, a novel fluoroquinolone, with other quinolones and oral cephalosporins tested against 5086 recent clinical isolates.
Topics: Anti-Infective Agents; Bacteria, Aerobic; Cefixime; Cefotaxime; Cefuroxime; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1993 |
Comparative efficacies of ofloxacin, cefotaxime, and doxycycline for treatment of experimental epididymitis due to Escherichia coli in rats.
Topics: Animals; Cefotaxime; Doxycycline; Epididymitis; Escherichia coli; Escherichia coli Infections; Male; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar | 1993 |
Multidrug-resistant Salmonella typhi in Pakistani children: clinical features and treatment.
Topics: Ampicillin Resistance; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Chloramphenicol Resistance; Drug Resistance, Multiple; Female; Humans; Infant; Male; Ofloxacin; Pakistan; Salmonella typhi; Trimethoprim Resistance; Typhoid Fever | 1996 |
[Immunotropic activity of antimicrobial agents used in tuberculosis].
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Cefotaxime; Cephalosporins; Erythromycin; Isoniazid; Macrophages; Mice; Ofloxacin; Time Factors; Tuberculosis | 1996 |
A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Cefotaxime; Ciprofloxacin; Cohort Studies; Drug Prescriptions; Female; Humans; Male; Middle Aged; Norfloxacin; Ofloxacin; Pregnancy; Product Surveillance, Postmarketing; Treatment Outcome | 1996 |
Treatment of experimental endocarditis due to ampicillin-susceptible or ampicillin-resistant Salmonella enteritidis.
Topics: Ampicillin; Ampicillin Resistance; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Endocarditis, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Rabbits; Salmonella enteritidis; Salmonella Infections | 1996 |
The bactericidal activity of levofloxacin compared with ofloxacin, D-ofloxacin, ciprofloxacin, sparfloxacin and cefotaxime against Streptococcus pneumoniae.
Topics: Anti-Infective Agents; Cefotaxime; Ciprofloxacin; Colony Count, Microbial; Fluoroquinolones; Levofloxacin; Ofloxacin; Quinolones; Streptococcus pneumoniae | 1997 |
[Stage-oriented antibiotic therapy of peritonitis. Prospective study].
Topics: Anti-Infective Agents; Bacterial Infections; Cefotaxime; Cephalosporins; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Metronidazole; Ofloxacin; Peritoneal Lavage; Peritonitis; Prognosis; Prospective Studies; Surgical Wound Infection; Survival Analysis | 1997 |
Antimicrobial interactions (synergy) of teicoplanin with two broad-spectrum drugs (cefotaxime, ofloxacin) tested against gram-positive isolates from Germany and the United States.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Resistance, Multiple; Drug Synergism; Germany; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Ofloxacin; Teicoplanin; United States | 1997 |
Simultaneous quantification of cefotaxime, desacetylcefotaxime, ofloxacine and ciprofloxacine in ocular aqueous humor and in plasma by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aqueous Humor; Cefotaxime; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Lens, Crystalline; Ofloxacin | 1997 |
Transfer of antibiotic resistance and production of extended-spectrum beta-lactamase (ESBL) in nosocomial Klebsiella pneumoniae strains from two hospitals in Czech Republic.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Ceftazidime; Cephalosporin Resistance; Cephalothin; Czech Republic; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Ofloxacin | 1997 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Serum bactericidal activity of levofloxacin against Streptococcus pneumoniae.
Topics: Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Serum Bactericidal Test; Streptococcus pneumoniae | 1999 |
Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998.
Topics: Anti-Bacterial Agents; Bacterial Capsules; Cefotaxime; Chloramphenicol; Clindamycin; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant, Newborn; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Sepsis; Serotyping; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Vancomycin | 2000 |
Multiple organ failure complicating probable scrub typhus.
Topics: Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Female; Humans; Infant, Newborn; Multiple Organ Failure; Ofloxacin; Orientia tsutsugamushi; Scrub Typhus; Treatment Outcome | 2000 |
Bacteremia and possible endocarditis caused by Moraxella phenylpyruvica.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Humans; Male; Moraxella; Neisseriaceae Infections; Ofloxacin; Penicillins | 2000 |
Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to cefditoren, and provisional interpretive criteria.
Topics: Ampicillin; Anti-Infective Agents; Cefaclor; Cefotaxime; Cephalosporin Resistance; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Streptococcus pneumoniae | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Emergence of extremely high penicillin and cefotaxime resistance and high-level levofloxacin resistance in clinical isolates of Streptococcus pneumoniae in Hungary.
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Humans; Hungary; Levofloxacin; Ofloxacin; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 2001 |
Bacteriology and antimicrobial susceptibility of gram-positive cocci isolated from pus specimens of orofacial odontogenic infections.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefazolin; Cefotaxime; Cephalosporins; Clindamycin; Corynebacterium; Drug Resistance, Bacterial; Erythromycin; Eubacterium; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Peptostreptococcus; Periodontitis; Staphylococcus; Streptococcus; Sulbactam; Thienamycins; Tooth Diseases | 2002 |
Therapeutic re-appraisal of multiple drug resistant Salmonella typhi (MDRST) in Pakistani children.
Topics: Amoxicillin; Cefotaxime; Ceftriaxone; Child; Child, Preschool; Chloramphenicol; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pakistan; Prognosis; Retrospective Studies; Salmonella typhi; Treatment Failure; Treatment Outcome; Typhoid Fever | 2002 |
In vitro and in vivo activities of fluoroquinolones against Aeromonas hydrophila.
Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Cefotaxime; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Levofloxacin; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Ofloxacin; Quinolines; Quinolones | 2003 |
Cefotaxime acts synergistically with levofloxacin in experimental meningitis due to penicillin-resistant pneumococci and prevents selection of levofloxacin-resistant mutants in vitro.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Drug Synergism; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Mutation; Ofloxacin; Penicillin Resistance; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; Streptococcus pneumoniae | 2003 |
High level of resistance to levofloxacin of Streptococcus pneumoniae following fluoroquinolone therapy.
Topics: Aged; Cefotaxime; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Follow-Up Studies; Humans; Infusions, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Ofloxacin; Pneumonia, Pneumococcal; Risk Assessment; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2003 |
[Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; China; Chloramphenicol; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Rifampin; Streptococcus pneumoniae; Tetracycline; Trimethoprim | 2004 |
Comparison of cefotaxime and ofloxacin in treatment of spontaneous bacterial peritonitis.
Topics: Adult; Aged; Analysis of Variance; Cefotaxime; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Liver Cirrhosis; Male; Middle Aged; Ofloxacin; Peritonitis; Probability; Prospective Studies; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
E-test method for detecting antibiotic synergy against Pseudomonas aeruginosa from neutropenic patients: a cost-effective approach.
Topics: Anemia; Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Fluoroquinolones; Hematologic Neoplasms; Humans; Levofloxacin; Microbial Sensitivity Tests; Neutropenia; Ofloxacin; Piperazines; Pseudomonas aeruginosa; Pseudomonas Infections | 2004 |
Monotherapy in severe community-acquired pneumonia: is it worthy?
Topics: Anti-Bacterial Agents; Cefotaxime; Community-Acquired Infections; Drug Therapy, Combination; Humans; Ofloxacin; Pneumonia, Bacterial; Randomized Controlled Trials as Topic | 2005 |
Antibiotic susceptibility of slime-producing isolates from orthopedic patients.
Topics: Anti-Bacterial Agents; Cefotaxime; Clindamycin; Colony-Forming Units Assay; Humans; Imipenem; Microbial Sensitivity Tests; Miocamycin; Myxococcales; Ofloxacin; Orthopedic Procedures; Postoperative Complications | 1989 |
Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Chloramphenicol; Ciprofloxacin; Clindamycin; Drug Resistance, Multiple; Erythromycin; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Penicillins; Population Surveillance; Portugal; Retrospective Studies; Serotyping; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2006 |
Antimicrobial susceptibility of cerebrospinal isolates from patients with meningitis.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Meningitis, Bacterial; Microbial Sensitivity Tests; Neisseria meningitidis; Ofloxacin; Penicillins; Staphylococcal Infections; Staphylococcus aureus; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 2007 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Aural myiasis in a 1-day-old neonate.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefotaxime; Diptera; Drug Therapy, Combination; Ear Canal; Ear Diseases; Female; Humans; Infant, Newborn; Myiasis; Ofloxacin | 2008 |
[Primary Salmonella vascular graft infection and conservative treatment].
Topics: Aged; Amikacin; Anti-Bacterial Agents; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Vessel Prosthesis; Cefotaxime; Ceftriaxone; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Femoral Artery; Humans; Laparotomy; Male; Ofloxacin; Oxacillin; Popliteal Artery; Prosthesis-Related Infections; Recurrence; Salmonella Infections; Salmonella typhimurium; Shock, Septic | 2008 |
Polyarticular septic arthritis due to Moraxella canis revealing multiple myeloma.
Topics: Animals; Anti-Bacterial Agents; Arthritis, Infectious; Cefotaxime; Diagnosis, Differential; Disease Vectors; Dog Diseases; Dogs; Humans; Immunocompromised Host; Male; Middle Aged; Moraxella; Moraxellaceae Infections; Multiple Myeloma; Ofloxacin | 2009 |
Drug-resistance in Streptococcus pneumoniae isolates among Spanish middle aged and older adults with community-acquired pneumonia.
Topics: Aged; Aged, 80 and over; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Blood; Cefotaxime; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Oxacillin; Pneumococcal Infections; Serotyping; Spain; Sputum; Streptococcus pneumoniae | 2009 |
A recent evaluation of empirical cephalosporin treatment and antibiotic resistance of changing bacterial profiles in spontaneous bacterial peritonitis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefepime; Cefotaxime; Cephalosporins; Drug Resistance, Bacterial; Enterococcus; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Klebsiella Infections; Klebsiella pneumoniae; Leukocyte Count; Levofloxacin; Liver Cirrhosis; Male; Microbial Sensitivity Tests; Middle Aged; Neutrophils; Ofloxacin; Peritonitis; Pneumococcal Infections; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections | 2010 |
[Spontaneous bacterial peritonitis].
Topics: Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Humans; Ofloxacin; Peritonitis; Primary Prevention; Renal Insufficiency; Secondary Prevention | 2009 |
Serotype distribution and susceptibility of Streptococcus pneumoniae isolates from pleural fluid in Spain from 1997 to 2008.
Topics: Adolescent; Adult; Body Fluids; Cefotaxime; Humans; In Vitro Techniques; Ofloxacin; Penicillins; Pleural Effusion; Serotyping; Streptococcus pneumoniae; Young Adult | 2010 |
Liver abscess and empyema due to Lactococcus lactis cremoris.
Topics: Adult; Anti-Bacterial Agents; Cefotaxime; Drainage; Empyema; Gram-Positive Bacterial Infections; Humans; Lactococcus lactis; Levofloxacin; Liver Abscess; Male; Microbial Sensitivity Tests; Ofloxacin; Thoracic Surgery, Video-Assisted; Tomography, X-Ray Computed | 2010 |
[A case of acute phlegmonous gastritis causing gastroparesis and cured with medical treatment alone].
Topics: Acinetobacter; Acute Disease; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Gastritis; Gastroparesis; Gastroscopy; Humans; Imipenem; Klebsiella oxytoca; Male; Ofloxacin; Pneumonia; Tomography, X-Ray Computed | 2011 |
Prevalence and risk factors for unsuspected spontaneous ascitic fluid infection in cirrhotics undergoing therapeutic paracentesis in an outpatient clinic.
Topics: Adult; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Cefotaxime; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Ofloxacin; Outpatients; Paracentesis; Peritonitis; Prevalence; Risk Factors | 2011 |
Polyamines reduce oxidative stress in Escherichia coli cells exposed to bactericidal antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Gene Expression Regulation, Bacterial; Hydrogen Peroxide; Microbial Sensitivity Tests; Ofloxacin; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Oxidative Stress; Putrescine; Spermidine; Superoxides; Trans-Activators | 2012 |
Occurrence and antibacterial susceptibility pattern of bacterial pathogens isolated from diarrheal patients in Pakistan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bacillus cereus; Cefotaxime; Child; Child, Preschool; Cross-Sectional Studies; Diarrhea; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pakistan; Pseudomonas aeruginosa; Pseudomonas Infections; Salmonella typhi; Staphylococcal Infections; Staphylococcus aureus; Typhoid Fever; Young Adult | 2016 |
Genetic diversity study of various β-lactamase-producing multidrug-resistant
Topics: beta-Lactam Resistance; beta-Lactamases; Cefotaxime; Colistin; DNA, Intergenic; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genetic Variation; Humans; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Tertiary Care Centers | 2017 |
Multidrug resistance, prevalence and phylogenetic analysis of genes encoding class II and III integrons in clinically isolated Escherichia coli.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Base Sequence; Cefotaxime; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gene Expression Regulation, Bacterial; Gentamicins; Hospitals; Humans; Imipenem; Integrons; Microbial Sensitivity Tests; Nalidixic Acid; Ofloxacin; Phylogeny; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Sequence Alignment | 2018 |
Rapid chiral separation of potential antibiotics using supercritical fluid chromatography.
Topics: Anti-Bacterial Agents; Cefotaxime; Chromatography, High Pressure Liquid; Chromatography, Supercritical Fluid; Ofloxacin; Stereoisomerism | 2022 |